Navigation Links
NYC Benefit Raises $1.4m for the Damon Runyon Cancer Research Foundation, Honors Merck
Date:6/4/2009

NEW YORK, June 4 /PRNewswire-USNewswire/ -- A charity breakfast at New York's Rainbow Room on May 27th raised $1.4 million for innovative cancer research funded by the Damon Runyon Cancer Research Foundation. The Foundation gives 100% of donations to exceptional early-career cancer researchers, who are funded through competitive and prestigious award programs, targeting all types of cancers.

The non-profit's Annual Breakfast featured remarks by Joe Kernen, co-anchor of CNBC's flagship morning program "Squawk Box," who spoke of his previous role as a cancer researcher at MIT. "The people that pushed me out of research and into reading a teleprompter are the people that win Damon Runyon awards," said Mr. Kernen.

Photos of the event can be found here.

Richard T. Clark, Chairman, President and Chief Executive Officer of Merck & Co., Inc., was honored at the May 27 event for his company's commitment to scientific discovery. In remarks at the breakfast, Mr. Clark said, "This is an amazing time to be involved in cancer research. But no one company, individual, or organization can do it alone. I applaud the Foundation and its scientists for their important work." Merck recently donated $450,000 towards the Damon Runyon Clinical Investigator program, which aims to accelerate the translation of research into new treatments and cures for cancer patients. Since 1995, the company has provided $2 million to support Damon Runyon Fellowships.

Mr. Clark was introduced by Larry Bossidy, former CEO of Honeywell International Inc. Mr. Bossidy recently retired from Merck's Board of Directors.

Damon Runyon scientists John L. Rinn, PhD, and Christine H. Chung, MD, described their current cancer research projects funded by the Foundation:

Dr. Rinn, previously an aspiring professional snowboarder and now an Assistant Professor at the Broad Institute of MIT and Harvard University, won a Damon Runyon Innovation Award for his work on a new class of molecules called lincRNAs, which have potentially groundbreaking possibilities for the treatment of all cancers.

"We do genomic origami. If we could learn to fold, say, a broken wing [of a genomic origami bird] up, we could turn a cancerous cell back to normal," said Dr. Rinn.

Dr. Chung's story brought her from a house in South Korea without indoor plumbing to her current role as a Damon Runyon Clinical Investigator now focused on improving treatments for patients with head and neck cancers.

"I deeply appreciate Damon Runyon's support - it helped me achieve my American dream," said Dr. Chung, who is now Assistant Professor of Medicine at Vanderbilt University Medical Center.

"Breakthroughs happen when you let the most brilliant people test their ideas and follow their instincts," said Lorraine Egan, Executive Director of the Damon Runyon Cancer Research Foundation. Ms. Egan highlighted the recent work of Damon Runyon scientist Cassian Yee, MD, who successfully treated a patient with advanced melanoma with immunotherapy.

The Annual Breakfast was attended by 250 guests including leaders of science, academia and industry.

About the Damon Runyon Cancer Research Foundation

The Damon Runyon Cancer Research Foundation invests in the rising stars of science and the most innovative cancer research.

Eleven scientists supported by the Foundation have received the Nobel Prize, and others are heads of cancer centers and leaders of renowned research programs. The Foundation currently is funding more than 100 scientists at leading medical centers and research institutions. Since its founding in 1946, the Foundation has invested over $220 million and funded more than 3,200 young scientists. This year, it will invest approximately $9 million in brilliant young minds.

100% of all direct donations are used to support scientific research. Low administrative costs are paid through the Damon Runyon Broadway Tickets service and endowment.


'/>"/>
SOURCE Damon Runyon Cancer Research Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Antioxidants show no clear benefit against cardiovascular events, death in high-risk women
2. Ambulatory oxygen rarely a benefit in COPD patients without resting hypoxemia
3. Discovery of sugar sensor in intestine could benefit diabetes
4. Study shines more light on benefit of vitamin D in fighting cancer
5. Vitamin Es lack of heart benefit linked to dosage
6. Practice-based intervention has sustained benefits for children and families
7. Manic phase of bipolar disorder benefits from breast cancer medication
8. Medicare Prescription Drug Benefit, Nonprofit Hospitals, Ambulatory Surgery Centers, Statistical Methods, and Pay-For-Performance Highlighted In the Latest INQUIRY Journal
9. Scientists highlight benefits of genetic research in sport, but warn of ethical concerns
10. The Butterfly Ball to Benefit Lung Association
11. Smaller breast reduction surgeries provide health benefits and should be reimbursed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... CURE Media Group, the ... advocacy groups, has aligned with Upstage Lung Cancer in efforts to combat lung cancer, ... Michael J. Hennessy, Jr said, “CURE Media Group is honored to team up with ...
(Date:12/8/2016)... ... ... Fitness Camp (PFC) and The Chopra Center for Wellbeing announced today the launch of ... headquarters of Omni La Costa Resort & Spa in San Diego. , Chopra FIT ... development, a healthy lifestyle, or mental and physical healing. The week-long wellness program combines ...
(Date:12/8/2016)... N.J. (PRWEB) , ... December 08, 2016 , ... ... delivery technologies and development solutions for drugs, biologics and consumer health products, today ... PSCI was set up in 2006 as a non-profit organization to unite pharmaceutical ...
(Date:12/8/2016)... ... 08, 2016 , ... California Senate Bill (SB) 863, signed into law in ... 2013 and 2014, according to CompScope™ Medical Benchmarks for California, 17th Edition , ... the study, medical payments per claim in California decreased 4 percent in 2013 and ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... Vida ... raised an $18M Series B led by Canvas Ventures . Other investors include ... to scale its mobile platform to serve more consumers who are managing chronic ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... -- A Small Business Innovative Research (SBIR) grant has ... to Phoenix -based NeuroEM Therapeutics, Inc. ... will seek to determine an optimal set of treatment ... to treat Alzheimer,s Disease. The grant will also investigate ... other neurologic disorders such as Parkinson,s Disease and PTSD. ...
(Date:12/8/2016)... in the United States will continue in 2017, say ... December 2016 Semiannual Economic Forecast. Expectations are for a ... as indicated in the monthly ISM ® ... is optimistic about growth in 2017, with revenues expected ... sector indicates that 14 of its industries will see ...
(Date:12/8/2016)...  Hanson Research, an innovative leader in the ... testing instruments for the pharmaceutical industry, announced today ... ("Teledyne"). The move is designed to deepen investments ... as well as expand resources for further market ... services. Logo - http://photos.prnewswire.com/prnh/20161208/446988LOGO ...
Breaking Medicine Technology: